Do you honestly want to invest in stocks right now? It sure looks like the bull market is at least on spring break, if not over. But, if you are interested in putting some money to work just in case the pivot higher is right around the corner, then two firms say buy Facebook Inc (NASDAQ:FB).
Cantor Fitzgerald and Pivotal Research upgraded the social site leader to "Buy" from "Hold" recommendations. Both research teams set a price-target of $72, which is not a coincidence as they are both written by the same guy.
For the few who may not know, Facebook, Inc. (Facebook) is engaged in building products to create utility for users, developers, and advertisers. People use Facebook to stay connected with their friends and family, to discover what is going on in the world around them, and to share and express what matters to them to the people they care about. Developers can use the Facebook Platform to build applications and Websites that integrate with Facebook to reach its global network of users and to build personalized and social products. It offers advertisers a combination of reach, relevance, social context and engagement.
5 Best Blue Chip Stocks For 2015: CryoPort Inc (CYRX)
Cryoport, Inc. (CryoPort), incorporated on May 25, 1990, provides frozen shipping logistics solutions to the biotechnology and life science industries. The Company�� solutions are disruptive to old technologies and provide reliable, economic alternatives to existing products and services utilized for frozen shipping in biotechnology and life sciences including stem cells, cell lines, vaccines, diagnostic materials, semen and embryos for in-vitro fertilization, cord blood, bio-pharmaceuticals, infectious substances and other items that require continuous exposure to frozen or cryogenic temperatures.
The Company offer its solutions to companies in the biotechnology and life sciences industries and specific verticals including manufacturers of stem cells and cell lines, diagnostic laboratories, bio-pharmaceuticals, contract research organizations, in-vitro fertilization, cord blood, vaccines, tissue, animal husbandry, and other producers of commodities requiring reliable frozen solutions for logistics problems.
The CryoPort Express System
Cryoport Express Solutions include a cloud-based logistics management software branded as the Cryoportal. The Cryoportal supports the management of the entire shipment process through a single interface which includes initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport�� total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides green, environmentally friendly solutions. The Cryoportal provides an array of information dashboards and validation documentation for every shipment.
Cryoport Express Solutions include recording and retaining a fully documented chain-of-custody and, at the client�� option, chain-of-condition for every shipment, helping ensure that safety, efficacy, and stability of shipped commodities are maintained. This re! corded and archived information allows its customers to meet the exacting requirements necessary for scientific work and for regulatory purposes. Cryoport Express Solutions can be used by customers, as a turnkey solution, through direct access to the cloud-based Cryoportal, or by contacting Cryoport Client Care for order entry tasks. Cryoport provides 24/7/365 logistics services through its Client Care team and also provides complete training and process management services to support each client�� specific requirements.
The CryoPort Express System
The CryoPort Express System consists of the CryoPort Express Portal, which programmatically manages order entry and all aspects of shipping operations, CryoPort Express Shippers, the CryoPort Express Smart Pak data logger, and CryoPort Express Analytics, which monitors shipment performance metrics and evaluates temperature-monitoring data collected by the data logger during shipment. In addition, the Company provides a containment bag, which is used in connection with the shipment of infectious or dangerous goods using the CryoPort Express Shipper and other accessories used in the shipment of biological and pharmaceutical specimens.
CryoPort Express Portal
The CryoPort Express Portal is used by CryoPort, the Company�� customers and its business partners to automate the entry of orders, prepare customs documentation and to facilitate status and location monitoring of shipped orders while in transit it is used by CryoPort to manage shipping operations. It is also used to support the high level of customer service. The CryoPort Express Portal also serves as the communications nerve center for the management, collection and analysis of Smart Pak data collected from Smart Pak data loggers in the field.
The CryoPort Express Shippers
The Company�� CryoPort Express Shippers are cryogenic dry vapor shippers capable of maintaining cryogenic temperatures of minus 150掳 Celsius or below f! or a peri! od of 10 or more days. A dry cryogenic shipper is a device that uses liquid nitrogen contained inside a vacuum insulated bottle, which serves as a refrigerant to provide stable storage temperatures below minus 150掳 Celsius. It has developed a retention system to ensure that liquid nitrogen stays inside the vacuum container, which allows the shipper to be designated as a dry shipper meeting International Air Transport Association (IATA) requirements. The Company is offering two sizes of dry vapor shippers, the CryoPort Express Standard Shipper with a storage capacity of up to 75 0.2 milliliter vials and the CryoPort Express High Volume Shipper, which was introduced, in January of 2012 with a capacity of up to 500 0.2 milliliter vials.
The CryoPort Express Standard Shipper
The Standard CryoPort Express Shippers are lightweight, re-usable dry vapor liquid nitrogen storage containers. A Standard CryoPort Express Shipper is composed of an aluminum metallic dewar flask, with a well for holding the biological material in the inner chamber.
The CryoPort Express High Volume Shippers
The Cryoport Express High Volume Shipper also uses a dry vapor liquid nitrogen (LN2) technology to maintain below -150掳 C temperatures with a dynamic shipping endurance of 10 days. The CryoPort Express High Volume dry shipper uses a dry vapor liquid nitrogen (LN2) technology to maintain below -150掳 Celsius temperatures. The High Volume dry shipper has a storage capacity of up to 500 0.2 milliliter vials.
The CryoPort Express Smart Pak
Phase II of the Company�� Smart Pak System, which is a self-contained automated data logger capable of recording the internal and external temperatures of samples shipped in its CryoPort Express Shipper is used in every shipment. Phase III of its Smart Pak System consists of developing and rolling out a chip with wireless connectivity to enable its customers to monitor a shipper�� location, specimen temperature and over! all state! of health via its Web portal. The Company is developing the requirements for Phase III.
Cryoport Express Analytics
The Cryoportal is an important information technology element of its business strategy and has been designed to support planned future features to allow for an expansion of its solutions offering. Analytics is a term used by IT professionals to refer to performance benchmarks or Key Performance Indicators (KPI��) that management utilizes to measure performance against desired standards. Examples for analytics tracked through the Cryoportal include time-based metrics for order processing time and on-time deliveries by its shipping partners, as well as profiling shipping lanes to determine average transit times and predicting potential shipping exceptions based on historical metrics.
Biological Material Holders
The Company has developed a containment bag, which is used in connection with the shipment of infectious or dangerous goods using the CryoPort Express Shipper. Up to five vials, watertight primary receptacles are placed onto aluminum holders and up to fifteen holders (75 vials) are placed into an absorbent pouch, which is designed to absorb the entire contents of all the vials in the event of leakage. This pouch containing up to 75 vials is then placed in a watertight secondary packaging Tyvek bag capable of withstanding cryogenic temperatures, and then sealed. This bag is then placed into the well of the cryogenic shipper.
The Company competes with MVE/Chart Industries, Taylor Wharton and Air Liquide, Marathon Products Inc., Kodiak Thermal Technologies, Inc, BioStorage Technologies and BioMatrica, Inc.
Advisors' Opinion:- [By CRWE]
Today, CYRX has shed (-10.00%) down -0.050 at $.450 with�179,695 shares in play thus far (ref. google finance Delayed: 12:35PM EDT October 4, 2013).
Cryoport, Inc. and OCASA, Inc. have previously entered into a master services agreement to provide global cold chain logistics solutions for life science and biotech commodities requiring cryogenic temperatures. OCASA will have access to Cryoport�� full range of cryogenic business solution capabilities including its proprietary Cryoport Express庐 Shippers and cloud-based logistics management software platform, the CryoportalTM. Cryoport will leverage OCASA�� global logistics network to provide more complete global services to its customers. In conjunction with Cryoport and OCASA providing each other with logistics solutions, the Companies will engage in co-marketing, joint sales activities, and a wide range of customer-driven support requirements to provide comprehensive and seamless solutions to the life sciences and biotech industries
Top 10 Building Product Stocks To Own For 2014: Boston Therapeutics Inc (BTHE)
Boston Therapeutics, Inc. is a development-stage company. The Company�� business is the development, manufacture and commercialization of therapeutic drugs and dietary supplements with a focus on glyco-pathology, a specialized field involving understanding the importance of carbohydrates in biochemistry and progression of diseases. The Company is focusing on three products: IPOXYN, an injectable anti-hypoxia drug, which it is developing; PAZ320, which is a non-systemic, chewable drug candidate for reduction of blood glucose in diabetics in development and SUGARDOWN, a complex carbohydrate-based chewable dietary supplement, which it is marketing. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the class of carbohydrate-hydrolyzing enzyme inhibitors.
SUGARDOWN
The Company has developed SUGARDOWN, a non-systemic complex carbohydrate-based dietary supplement to moderate post-meal blood glucose using processes and technology. It has unrestricted access to both sufficient raw materials at commodity pricing and processing facilities to produce sufficient supply of SUGARDOWN to support product distribution across multiple sales channels as a dietary supplement. Its SUGARDOWN dietary supplement consists of a stabilized complex carbohydrate composition. The Company has completed development of SUGARDOWN as a dietary supplement. On January 24, 2012 the Company announced the clinical trial results in healthy volunteers performed at the University of Sydney on SUGARDOWN.
PAZ320
PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes, which release glucose from complex carbohydrate in foods during digestion, reducing the amount of available glucose absorbed through the intestine. PAZ320 is in development as a drug candidate. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the! class of carbohydrate-hydrolyzing enzyme inhibitors.
IPOXYN
The Company has developed a drug candidate product IPOXYN, a glyco-protein based therapeutic agent. Its IPOXYN anti-hypoxia drug consists of a stabilized glycoprotein composition containing oxygen-rechargeable iron, targeting both human and animal tissues and organ systems deprived of oxygen and in need of metabolic support. In addition to potential uses for human patients, it also focuses to file a registration for IPOXYN for veterinary applications under the name OXYFEX. The Company�� pharmaceutical agents are intended for intravenous administration into the circulatory system to target acute and late stage diseases.
Advisors' Opinion:- [By CRWE]
Today, BTHE remains (0.00%) +0.000 at $1.10 thus far (ref. google finance Delayed: 12:25PM EDT October 10, 2013).
Boston Therapeutics has previously closed the final tranche of approximately $1.8 million to bring total gross proceeds of approximately $5.3 million from the private placement of Common Stock and warrants to existing and new accredited investors (the “Offering”).
Proceeds of the offering will be used to fund additional clinical trials for PAZ320, a non-systemic chewable drug designed to reduce the elevation of postprandial glucose or post-meal blood sugar for treatment of patients with Type 2 diabetes, and for general corporate purposes. PAZ320 is the first compound in a new class of therapies for this disease.
Top 10 Building Product Stocks To Own For 2014: Amanasu Techno Holdings Corp (ANSU)
Amanasu Techno Holdings Corporation, incorporated on December 1, 1997, is a development-stage company. The Company focuses on acquiring the technologies, constructing four proto-type motor scooters and various testing of the technologies and the motor scooter.
As of December 31, 2012, the Company had not conducted any operations. As of December 31, 2012, the Company had not generated any revenues.
Advisors' Opinion:- [By Peter Graham]
Last Friday, small cap biotech or tech stocks Amanasu Techno Holdings Corp (OTCMKTS: ANSU), Bio Matrix Scientific Group Inc (OTCMKTS: BMSN) and Thinspace Technology Inc (OTCBB: THNS) surged 44.74%, 42.31% and 14%, respectively, with only one of these small caps appearing to be the subject of some sort of small paid promotions or investor relations campaign. Given the lack of a big pump from promoters or IR people, will these three small caps keep surging or will the tide go out again this week? Here is a quick reality check to help you decide on a trading or investing strategy:
Top 10 Building Product Stocks To Own For 2014: Health Net Inc. (HNT)
Health Net, Inc., through its subsidiaries, provides managed health care services. The company offers commercial health care products, such as health maintenance organization plans through contracts with participating network physicians, hospitals, and other providers; preferred provider organization plans that provide coverage for services received from health care provider; and point of service plans. It also provides Medicare products, including Medicare advantage plans with and without prescription drug coverage; and Medicare supplement products that supplement fee-for-service Medicare coverage. In addition, the company offers Medicaid and related products; indemnity insurance products; auxiliary non-health products, such as life, accidental death and dismemberment, dental, vision, and behavioral health insurance; and other specialty services and products comprising pharmacy benefits, behavioral health, dental, and vision products and services, as well as managed care products for hospitals, health plans, and other entities. Further, it engages in government-sponsored managed care federal contract with the Department of Defense under the TRICARE program in the North Region; and other health care, mental health, and behavioral health government contracts. The company provides administrative services comprising provider network and referral management, medical and disease management, enrollment, customer service, clinical support service, and claims processing service to military health system eligible beneficiaries. It serves approximately 5.4 million individuals in the United States through group, individual, Medicare, Medicaid, the U.S. Department of Defense, and Veterans Affairs programs. Health Net, Inc. was founded in 1979 and is headquartered in Woodland Hills, California.
Advisors' Opinion:- [By Roberto Pedone]
Health Net (HNT) is an integrated managed care organization that delivers managed health care services through health plans and government-sponsored managed care plans. This stock closed up 2.9% at $32.51 in Thursday's trading session.
Thursday's Volume: 1.17 million
Three-Month Average Volume: 665,534
Volume % Change: 65%From a technical perspective, HNT jumped higher here right above its 50-day moving average of $31.37 with above-average volume. This stock has been uptrending for the last few weeks, with shares moving higher from its low of $29.11 to its intraday high of $32.80. During that move, shares of HNT have been consistently making higher lows and higher highs, which is bullish technical price action. That move is starting to push shares of HNT within range of triggering a big breakout trade. That trade will hit if HNT manages to take out some near-term overhead resistance levels at $33.61 to its 52-week high at $33.70 with high volume.
Traders should now look for long-biased trades in HNT as long as it's trending above its 50-day at $31.37 and then once it sustains a move or close above those breakout levels with volume that's near or above 665,534 shares. If that breakout hits soon, then HNT will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $38 to its three-year high at $41.22.
- [By Sean Williams]
What: Shares of Health Net (NYSE: HNT ) , a managed health-care provider, jumped higher by as much as 18% following the release of the company's first-quarter earnings results. Shares have since given back a majority of their gains and are up "just" 7% as of this writing.
Top 10 Building Product Stocks To Own For 2014: Textron Inc.(TXT)
Textron Inc. operates in the aircraft, defense, automobile, industrial, and finance businesses worldwide. It operates in five segments: Cessna, Bell, Textron Systems, Industrial, and Finance. The Cessna segment manufactures business jets, single engine turboprops, and single engine piston aircraft, as well as provides aftermarket services. The Bell segment manufactures and supplies military and commercial helicopters, tiltrotor aircraft, and related spare parts and services. The Textron Systems segment produces armored security vehicles, marine craft, precision weapons, airborne and ground-based surveillance systems and services, the unmanned aircraft system, training and simulation systems and countersniper devices, and intelligence and situational awareness software. The Industrial segment offers blow-molded plastic fuel systems, windshield and headlamp washer systems, engine camshafts, plastic bottles, and containers; powered equipment, electrical test and measurement i nstruments, hand and hydraulic powered tools, and electrical and fiber optic assemblies principally used in the electrical construction and maintenance, plumbing, wiring, telecommunications, and data communications industries; and golf cars, professional turf-maintenance equipment, and off-road, multipurpose utility, and specialized turf-care vehicles that are marketed to golf courses, resort communities, municipalities, sporting venues, and commercial and industrial users. The Finance segment provides finance for aircraft, helicopters, and golf and turf-care equipment. The company sells its products through a network of sales representatives, distributors, and authorized independent sales representatives, as well as directly to end users, home improvement retailers, and original equipment manufacturers. Textron Inc. was founded in 1923 and is headquartered in Providence, the Rhode Island.
Advisors' Opinion:- [By Rich Smith]
Another year, another earnings season for Textron (NYSE: TXT ) .
On Wednesday, the Providence, R.I.-based defense contractor issued its first quarterly earnings release for fiscal 2013, and the news was -- there's really no way to sugarcoat it -- not great. Of course, you've probably already gathered that much from the stock's 13% sell-off, but here are the gory details:
Top 10 Building Product Stocks To Own For 2014: Companhia de Bebidas das Americas - AmBev(ABV)
Companhia de Bebidas das Americas?Ambev engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt, and other non-alcoholic and non-carbonated products in the Americas. It also sells bottled water, isotonics, and ready-to-drink teas. The company provides its products under the brand names of Skol, Brahma, Antarctica, Guarana Antarctica, Gatorade, Brahva, Brahva Beats, Extra, Brahma Light, Brahma Ice, Quilmes, Stella Artois, Red Rock, Pepsi-Cola, Seven UP, Zenda, Concordia, Triple Kola, Quilmes Cristal, Brahma, Andes, Pacena, Taquina, Huari, Becker, Baltica, Pilsen, Patricia, Labatt Blue, Alexander Keith?s, and Kokanee. It has a licensing agreement with Anheuser-Busch, Inc. to produce, bottle, distribute, and sell Budweiser products in Canada and Paraguay. Companhia de Bebidas das Americas?Ambev distributes its products through direct distribution system and third-party distributors. The company was founded in 1888 and is headquarter ed in Sao Paulo, Brazil. Companhia de Bebidas das Americas?Ambev is a subsidiary of Interbrew International B.V.
Advisors' Opinion:- [By Hilary Kramer]
Companhia de Bebidas das Americas (ABV): Better known as Ambev, it is one of the largest brewers in the world and the largest in Latin America (in terms of sales volume). It makes a variety of beverages, including beer and soft drinks, and is also one of the biggest independent PepsiCo bottlers in the world. The company has done a good job lately of emphasizing premium beers, which carry a higher margin, to offset recent lower sales volumes. ABV yields a solid 4.6%.
- [By Dividend]
Companhia de Bebidas Das Americas (ABV) has a market capitalization of $118.32 billion. The company employs 51,299 people, generates revenue of $14.120 billion and has a net income of $4.662 billion. Companhia de Bebidas Das Americas�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $6.829 billion. The EBITDA margin is 48.36 percent (the operating margin is 43.00 percent and the net profit margin 33.02 percent).
Top 10 Building Product Stocks To Own For 2014: Portland General Electric Company (POR)
Portland General Electric Company operates as an integrated electric utility in Oregon. The company engages in the generation, purchase, transmission, distribution, and retail sale of electricity. Its generating portfolio consists of thermal, hydro, and wind resources. The company also sells electricity and natural gas in the wholesale market to utilities, brokers, and power marketers in the western United States and Canada. As of March 31, 2011, it served approximately 821,193 residential, commercial, and industrial customers. The company was founded in 1930 and is headquartered in Portland, Oregon.
Advisors' Opinion:- [By Ben Levisohn]
The full list: Buffalo Wild Wings, Cavium, CaesarStone (CSTE), Eclipse Resources, MobileIron (MOBL), Nextera Energy, Portland General Electric (POR), Rexnord Corp, Terex Corp, Western Refining Logistics (WNRL), and The Advisory Board.
- [By Rich Duprey]
Utility operator�Portland General Electric� (NYSE: POR ) �announced yesterday�its second-quarter dividend of $0.275 per share, a near-2% increase over last quarter's payout of $0.27 per share.
No comments:
Post a Comment